ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HCM vs PGEN // ALTMAN Z-SCORE & DEBT/EQUITY

HUTCHMED (China) Limited (NASDAQ) VS. Precigen Inc. (NASDAQ) • 15-METRIC TALLY: HCM 6 — PGEN 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCM VS. PGEN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HCM PGEN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -2.50% -35.00% +32.50 HCM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.32% -3.78% +0.46 HCM /fcf-yield <GO>
Operating Margin -7.10% -60.00% +52.90 HCM /operating-margins <GO>
Net Profit Margin 68.00% -60.00% +128.00 HCM /net-margins <GO>
Revenue Growth (YoY) -13.00% 146.70% -159.70 PGEN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 3.63 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 HCM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.0 45.9 +1.10 HCM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 4.8x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.37B $2.38B -$6.4M PGEN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HCM REV PGEN REV HCM GROSS % PGEN GROSS % HCM FCF PGEN FCF
FY 2025 $548.5M $9.7M 38.7% — -$78.8M -$89.8M
FY 2024 $630.2M $3.9M 44.6% — -$17.4M -$76.8M
FY 2023 $838.0M $6.2M — — $219.3M -$66.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCM // BETA —
PGEN // BETA —